Lung Cancer Chemotherapy

Novelos Therapeutics Believes Class Action Lawsuit Is Without Merit And ... - TheStreet.com (subscription)
( Wed, 10 Mar 2010 13:38:14 GMT+00:00 )

Novelos Therapeutics Believes Class Action Lawsuit Is Without Merit And ...
TheStreet.com (subscription)
... thereunder in connection with alleged disclosures related to the Phase 3 clinical trial of its compound NOV-002 for non-small cell lung cancer. ...

and more »

Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010 - PharmaLive (press release) (subscription)
( Wed, 10 Mar 2010 13:14:27 GMT+00:00 )

Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010
PharmaLive (press release) (subscription)
Lung cancer is a major public health issue with over 1 million new cases a year across the world, and accounts for some 450000 deaths per year in Europe and ...

and more »

Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010 - PharmaLive.com (press release)
( Wed, 10 Mar 2010 13:06:34 GMT+00:00 )

Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010
PharmaLive.com (press release)
Lung cancer is a major public health issue with over 1 million new cases a year across the world, and accounts for some 450000 deaths per year in Europe and ...

and more »

Walk to benefit JFCS services for local cancer patients & families - Jewish Community Voice
( Wed, 10 Mar 2010 15:10:15 GMT+00:00 )

Walk to benefit JFCS services for local cancer patients & families
Jewish Community Voice
Those include lung cancer, the leading cause of cancer death in the US; breast cancer, which affects one in eight women; skin cancer, which will be ...

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results - FOXBusiness
( Tue, 09 Mar 2010 13:46:02 GMT+00:00 )

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results
FOXBusiness
... non-small cell lung cancer with Kras or EGFR-activated tumours. Eligible patients include those who have not received chemotherapy treatment for their ...

and more »

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ... - PharmaLive (press release) (subscription)
( Wed, 10 Mar 2010 16:49:23 GMT+00:00 )

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ...
PharmaLive (press release) (subscription)
... thereunder in connection with alleged disclosures related to the Phase 3 clinical trial of its compound NOV-002 for non-small cell lung cancer. ...

and more »

Explore options for complementary approach to cancer treatment - Charlottetown, The Guardian
( Tue, 09 Mar 2010 14:04:01 GMT+00:00 )

Explore options for complementary approach to cancer treatment
Charlottetown, The Guardian
People take chemotherapy and radiation, known to be carcinogenic, on the chance that it can help beat cancer or slow it down, so why shouldn't they try ...

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ... - Earthtimes (press release)
( Wed, 10 Mar 2010 13:36:58 GMT+00:00 )

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ...
Earthtimes (press release)
... thereunder in connection with alleged disclosures related to the Phase 3 clinical trial of its compound NOV-002 for non-small cell lung cancer. ...

and more »

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results - TMCnet
( Wed, 10 Mar 2010 12:25:19 GMT+00:00 )

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
TMCnet
Phase 1b Clinical Trial of EMD 1201081 in Combination with Tarceva and Avastin in Non-small Cell Lung Cancer (NSCLC) In September 2009, ...

and more »

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results - Lifescience-online
( Thu, 11 Mar 2010 09:34:50 GMT+00:00 )

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
Lifescience-online
A presentation entitled "Antitumor activity of a novel dual agonist of TLR7 and TLR8 in a preclinical model of 3LL-C75 lung carcinoma in wild type, TLR7-/-, ...

Night sweats are a mystery - Telegraph-Journal
( Tue, 09 Mar 2010 10:06:06 GMT+00:00 )

Night sweats are a mystery
Telegraph-Journal
After both were removed and the tissue was tested, I did not have to undergo chemotherapy or radiation. My PSA was 0 for nine years, but it is now reading ...

and more »

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results - Genetic Engineering News (press release)
( Wed, 10 Mar 2010 12:49:32 GMT+00:00 )

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
Genetic Engineering News (press release)
A presentation entitled Antitumor activity of a novel dual agonist of TLR7 and TLR8 in a preclinical model of 3LL-C75 lung carcinoma in wild type, ...

and more »

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results - CNNMoney.com (press release)
( Tue, 09 Mar 2010 12:36:18 GMT+00:00 )

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results
CNNMoney.com (press release)
Of 19 evaluable patients with head and neck cancer, mostly squamous cell carcinoma of the head and neck refractory to prior platinum-based chemotherapy for ...

and more »

Norfolk woman warned of ovarian cancer - Norwich Evening News
( Tue, 09 Mar 2010 17:05:47 GMT+00:00 )

Norfolk woman warned of ovarian cancer
Norwich Evening News
Mrs Hanks had six round of chemotherapy followed by a hysterectomy and then another two rounds of chemotherapy. Because the condition is genetic it can ...

and more »

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results - Business Wire (press release)
( Wed, 10 Mar 2010 12:13:46 GMT+00:00 )

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
Business Wire (press release)
A presentation entitled Antitumor activity of a novel dual agonist of TLR7 and TLR8 in a preclinical model of 3LL-C75 lung carcinoma in wild type, ...

and more »

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results - Canada NewsWire (press release)
( Tue, 09 Mar 2010 12:33:06 GMT+00:00 )

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results
Canada NewsWire (press release)
... non-small cell lung cancer with Kras or EGFR-activated tumours. Eligible patients include those who have not received chemotherapy treatment for their ...

and more »

Complete the Form Below
and Unlock Your
Mobile Phone instantly!

Name

Email

Mobile/Cell Phone

How did you find us

belvederebike.com		Home Contact Us